Peloton Wealth Strategists 4 D Molecular Therapeutics, Inc. Transaction History
Peloton Wealth Strategists
- $242 Million
- Q4 2024
A detailed history of Peloton Wealth Strategists transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Peloton Wealth Strategists holds 25,000 shares of FDMT stock, worth $80,250. This represents 0.06% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$80,250
Previous $270,000
48.52%
% of portfolio
0.06%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding FDMT
# of Institutions
145Shares Held
46.5MCall Options Held
121KPut Options Held
33.2K-
Black Rock Inc. New York, NY4.9MShares$15.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$14.6 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY4.27MShares$13.7 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.95MShares$9.48 Million2.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$9.18 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $104M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...